Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1532-1545

  Vega, Francisco ^a   Davuluri, Yogesh ^a   Cho Vega, Jeong Hee ^a   Singh, Rajesh R ^a   Ma, Shuguang ^a   Wang, Rui Yu ^a   Multani, Asha S ^a   Drakos, Elias ^a   Pham, Lan V ^a   Lee, Yen Chiu Lin ^a   Shen, Long ^b   Ambrus, Julian ^b   Medeiros, L Jeffrey ^a   Ford, Richard J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cancer stem cells; Lymphoma cell lines; Side population; Tumour initiating cells

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; PROTEIN BCL 2;

ANEUPLOIDY; ANIMAL; ARTICLE; CANCER STEM CELL; CELL AGING; CELL CLONE; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL PROLIFERATION; DISEASE MODEL; MANTLE CELL LYMPHOMA; METABOLISM; MOUSE; PATHOLOGY; PHENOTYPE; TELOMERE; TUMOR CELL LINE;

ANEUPLOIDY; ANIMALS; ANTIGENS, CD34; ANTIGENS, CD38; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; CLONE CELLS; DISEASE MODELS, ANIMAL; LYMPHOMA, MANTLE-CELL; MICE; NEOPLASTIC STEM CELLS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-BCL-2; S PHASE; SUBCELLULAR FRACTIONS; TELOMERE;

BLASTOIDEA; MURINAE;

EID: 77955125866     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00865.x     Document Type: Article

References (53)

1. Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 2005, 15:494-501.
2. Clarke MF, Dick JE, Dirks PB. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006, 66:9339-44.
3. Goodell MA, Brose K, Paradis G. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996, 183:1797-806.
4. Zhou S, Schuetz JD, Bunting KD. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001, 7:1028-34.
5. Wang J, Guo LP, Chen LZ. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 2007, 67:3716-24.
6. Ho MM, Ng AV, Lam S. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007, 67:4827-33.
7. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997, 3:730-7.
8. Collins AT, Berry PA, Hyde C. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-51.
9. Li C, Heidt DG, Dalerba P. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67:1030-7.
10. O'Brien CA, Pollett A, Gallinger S. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007, 445:106-10.
11. Ricci-Vitiani L, Lombardi DG, Pilozzi E. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007, 445:111-5.
12. Mitsutake N, Iwao A, Nagai K. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology. 2007, 148:1797-803.
13. Chiba T, Kita K, Zheng YW. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology. 2006, 44:240-51.
14. Haraguchi N, Utsunomiya T, Inoue H. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells. 2006, 24:506-13.
15. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA. 2004, 101:781-6.
16. Larderet G, Fortunel NO, Vaigot P. Human side population keratinocytes exhibit long-term proliferative potential and a specific gene expression profile and can form a pluristratified epidermis. Stem Cells. 2006, 24:965-74.
17. Al-Hajj M, Wicha MS, Benito-Hernandez A. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003, 100:3983-8.
18. Singh SK, Hawkins C, Clarke ID. Identification of human brain tumour initiating cells. Nature. 2004, 432:396-401.
19. Roulland S, Navarro JM, Grenot P. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med. 2006, 203:2425-31.
20. Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene. 2004, 23:6524-34.
21. Jemal A, Thomas A, Murray T. Cancer statistics, 2002. CA Cancer J Clin. 2002, 52:23-47.
22. Ford RJ, Shen L, Lin-Lee YC. Development of a murine model for blastoid variant mantle-cell lymphoma. Blood. 2007, 109:4899-906.
23. Shen L, Zhang C, Wang T. Development of autoimmunity in IL-14alpha-transgenic mice. J Immunol. 2006, 177:5676-86.
24. Platet N, Mayol JF, Berger F. Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line. FEBS Lett. 2007, 581:1435-40.
25. Cho-Vega JH, Vega F, Schwartz MR. Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR. J Cutan Pathol. 2007, 34:535-42.
26. Darzynkiewicz Z, Bedner E, Li X. Laser-scanning cytometry: A new instrumentation with many applications. Exp Cell Res. 1999, 249:1-12.
27. Baerlocher GM, Lansdorp PM. Telomere length measurements using fluorescence in situ hybridization and flow cytometry. Methods Cell Biol. 2004, 75:719-50.
28. Laud PR, Multani AS, Bailey SM. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev. 2005, 19:2560-70.
29. Holm M, Thomsen M, Hoyer M. Optimization of a flow cytometric method for the simultaneous measurement of cell surface antigen, DNA content, and in vitro BrdUrd incorporation into normal and malignant hematopoietic cells. Cytometry. 1998, 32:28-36.
30. Vega F, Medeiros LJ, Leventaki V. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res. 2006, 66:6589-97.
31. Storms RW, Goodell MA, Fisher A. Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood. Blood. 2000, 96:2125-33.
32. Welm BE, Tepera SB, Venezia T. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol. 2002, 245:42-56.
33. Summer R, Kotton DN, Sun X. Side population cells and Bcrp1 expression in lung. Am J Physiol Lung Cell Mol Physiol 2003, 285:L97-104.
34. Terunuma A, Jackson KL, Kapoor V. Side population keratinocytes resembling bone marrow side population stem cells are distinct from label-retaining keratinocyte stem cells. J Invest Dermatol. 2003, 121:1095-103.
35. Bhatt RI, Brown MD, Hart CA. Novel method for the isolation and characterisation of the putative prostatic stem cell. Cytometry A. 2003, 54:89-99.
36. Zhou S, Morris JJ, Barnes Y. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci USA. 2002, 99:12339-44.
37. Xu JX, Morii E, Liu Y. High tolerance to apoptotic stimuli induced by serum depletion and ceramide in side-population cells: high expression of CD55 as a novel character for side-population. Exp Cell Res. 2007, 313:1877-85.
38. Bodnar AG, Ouellette M, Frolkis M. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998, 279:349-52.
39. Morrison SJ, Prowse KR, Ho P. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity. 1996, 5:207-16.
40. Alvi AJ, Clayton H, Joshi C. Functional and molecular characterisation of mammary side population cells. Breast Cancer Res. 2003, 5:R1-8.
41. Zhu X, Kumar R, Mandal M. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci USA. 1996, 93:6091-5.
42. Hirschmann-Jax C, Foster AE, Wulf GG. A distinct " side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA. 2004, 101:14228-33.
43. Patrawala L, Calhoun T, Schneider-Broussard R. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 2005, 65:6207-19.
44. Durand RE, Olive PL. Cytotoxicity, Mutagenicity and DNA damage by Hoechst 33342. J Histochem Cytochem. 1982, 30:111-6.
45. Montanaro F, Liadaki K, Schienda J. Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp Cell Res. 2004, 298:144-54.
46. Nadin BM, Goodell MA, Hirschi KK. Phenotype and hematopoietic potential of side population cells throughout embryonic development. Blood. 2003, 102:2436-43.
47. Uchida N, Dykstra B, Lyons K. ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status. Blood. 2004, 103:4487-95.
48. Kondo M, Wagers AJ, Manz MG. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003, 21:759-806.
49. Shi GM, Xu Y, Fan J. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. J Cancer Res Clin Oncol. 2008, 134:1155-63.
50. Gilbertson RJ, Rich JN. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer. 2007, 7:733-6.
51. Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol. 2000, 425:479-94.
52. Kang H, Watkins G, Douglas-Jones A. The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast. 2005, 14:360-7.
53. Kaplan RN, Riba RD, Zacharoulis S. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005, 438:820-7.